ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. Methods: RNA sequence, quantitative real-time PCR, and western blot were performed to detect gene expre...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420304849 |
id |
doaj-a5675bb3581c455f995a8d0fde6fbf48 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ning Sun Xinping Zhong Shengli Wang Kai Zeng Hongmiao Sun Ge Sun Renlong Zou Wei Liu Wensu Liu Lin Lin Huijuan Song Chi Lv Chunyu Wang Yue Zhao |
spellingShingle |
Ning Sun Xinping Zhong Shengli Wang Kai Zeng Hongmiao Sun Ge Sun Renlong Zou Wei Liu Wensu Liu Lin Lin Huijuan Song Chi Lv Chunyu Wang Yue Zhao ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function EBioMedicine ATXN7L3 Estrogen receptor α Co-regulator Deubiquitination modification Hepatocellular carcinoma |
author_facet |
Ning Sun Xinping Zhong Shengli Wang Kai Zeng Hongmiao Sun Ge Sun Renlong Zou Wei Liu Wensu Liu Lin Lin Huijuan Song Chi Lv Chunyu Wang Yue Zhao |
author_sort |
Ning Sun |
title |
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function |
title_short |
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function |
title_full |
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function |
title_fullStr |
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function |
title_full_unstemmed |
ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function |
title_sort |
atxn7l3 positively regulates smad7 transcription in hepatocellular carcinoma with growth inhibitory function |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2020-12-01 |
description |
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. Methods: RNA sequence, quantitative real-time PCR, and western blot were performed to detect gene expression. Chromatin immunoprecipitation was performed to detect possible mechanisms. Immunohistochemical stain was performed to examine the protein expression. Colony formation, cell growth curve and xenograft tumor experiments were performed to examine cell growth in vitro and in vivo. Findings: ATXN7L3 functions as a coactivator for ERα-mediated transactivation in HCC cells, thereby contributing to enhanced SMAD7 transcription. ATXN7L3 is recruited to the promoter regions of SMAD7 gene, thereby regulating histone H2B ubiquitination level, to enhance the transcription of SMAD7. A series of genes regulated by ATXN7L3 were identified. Moreover, ATXN7L3 participates in suppression of tumor growth. In addition, ATXN7L3 is lower expressed in HCC samples, and the lower expression of ATXN7L3 positively correlates with poor clinical outcome in patients with HCC. Interpretation: This study demonstrated that ATXN7L3 is a novel regulator of SMAD7 transcription, subsequently participating in inhibition of tumor growth in HCC, which provides an insight to support a previously unknown role of ATXN7L3 in HCC progression. Fund: This work was funded by 973 Program Grant from the Ministry of Science and Technology of China (2013CB945201), National Natural Science Foundation of China (31871286, 81872015, 31701102, 81702800, 81902889), Foundation for Special Professor of Liaoning Province, Natural Science Foundation of Liaoning Province (No.20180530072); China Postdoctoral Science Foundation (2019M651164). |
topic |
ATXN7L3 Estrogen receptor α Co-regulator Deubiquitination modification Hepatocellular carcinoma |
url |
http://www.sciencedirect.com/science/article/pii/S2352396420304849 |
work_keys_str_mv |
AT ningsun atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT xinpingzhong atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT shengliwang atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT kaizeng atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT hongmiaosun atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT gesun atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT renlongzou atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT weiliu atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT wensuliu atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT linlin atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT huijuansong atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT chilv atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT chunyuwang atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction AT yuezhao atxn7l3positivelyregulatessmad7transcriptioninhepatocellularcarcinomawithgrowthinhibitoryfunction |
_version_ |
1724386930819334144 |
spelling |
doaj-a5675bb3581c455f995a8d0fde6fbf482020-12-11T04:22:20ZengElsevierEBioMedicine2352-39642020-12-0162103108ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory functionNing Sun0Xinping Zhong1Shengli Wang2Kai Zeng3Hongmiao Sun4Ge Sun5Renlong Zou6Wei Liu7Wensu Liu8Lin Lin9Huijuan Song10Chi Lv11Chunyu Wang12Yue Zhao13Department of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang City, Liaoning Province, 110001, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, China; Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang City, Liaoning Province, 110004, ChinaDepartment of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, China; Corresponding author.Department of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang City, Liaoning Province 110122, China; Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang City, Liaoning Province 110001, China; Corresponding author.Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, with unmet need for the pharmacological therapy. The functions of ATXN7L3 in HCC progression are not known. Methods: RNA sequence, quantitative real-time PCR, and western blot were performed to detect gene expression. Chromatin immunoprecipitation was performed to detect possible mechanisms. Immunohistochemical stain was performed to examine the protein expression. Colony formation, cell growth curve and xenograft tumor experiments were performed to examine cell growth in vitro and in vivo. Findings: ATXN7L3 functions as a coactivator for ERα-mediated transactivation in HCC cells, thereby contributing to enhanced SMAD7 transcription. ATXN7L3 is recruited to the promoter regions of SMAD7 gene, thereby regulating histone H2B ubiquitination level, to enhance the transcription of SMAD7. A series of genes regulated by ATXN7L3 were identified. Moreover, ATXN7L3 participates in suppression of tumor growth. In addition, ATXN7L3 is lower expressed in HCC samples, and the lower expression of ATXN7L3 positively correlates with poor clinical outcome in patients with HCC. Interpretation: This study demonstrated that ATXN7L3 is a novel regulator of SMAD7 transcription, subsequently participating in inhibition of tumor growth in HCC, which provides an insight to support a previously unknown role of ATXN7L3 in HCC progression. Fund: This work was funded by 973 Program Grant from the Ministry of Science and Technology of China (2013CB945201), National Natural Science Foundation of China (31871286, 81872015, 31701102, 81702800, 81902889), Foundation for Special Professor of Liaoning Province, Natural Science Foundation of Liaoning Province (No.20180530072); China Postdoctoral Science Foundation (2019M651164).http://www.sciencedirect.com/science/article/pii/S2352396420304849ATXN7L3Estrogen receptor αCo-regulatorDeubiquitination modificationHepatocellular carcinoma |